By Brian Clark
Back in the 1950s, a bedridden man faced certain death from inoperable, terminal cancer.
Tumors the size of oranges had invaded the man’s neck, groin, chest, and abdomen. The patient’s only hope was a new experimental cancer drug called Krebiozen.
Three days after the initial treatment, the man was out of bed and joking with his nurses. …read more